← All trials
NCT02330926
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 1, 2015
- Primary completion
- Jan 1, 2019
- Completion date
- Aug 1, 2019
- First posted
- —
- Last posted
- —
- Enrollment
- 240
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- Norwegian University of Science and TechnologyLead sponsor
- The Beatson West of Scotland Cancer CentreCollaborator
- Queen Margaret Hospital, DunfermlineCollaborator
- Malteser Krankenhaus Seliger GerhardtCollaborator
- University of AlbertaCollaborator
- University of FreiburgCollaborator
- Kantonsspital AarauCollaborator
- Cancer Research UKCollaborator
- University of OttawaCollaborator
- University of EdinburghStudy director
- Osaka UniversityCollaborator
- Norwegian University of Science and TechnologyCollaborator
- Norwegian University of Science and TechnologyStudy director
- Cantonal Hospital of St. GallenCollaborator
- McGill UniversityCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.